Login
← Go Back
Krebs Biochemicals & Industries
KREBSBIO · Pharma > Pharmaceuticals & Drugs · Chairman: R T Ravi · MD: Pabitrakumar Kalipada Bhattacharyya · Listing date: Aug. 23, 1995 · Employees: 390 · Hyderabad · http://krebsbiochem.com
Stock Price vs Company Growth
1d
5.3%
1w
13.4%
1m
16.0%
3m
5.8%
6m
12.0%
1y
15.9%
5y
10.7%
all
4.7%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 62.1 5.3%
38.5
68
Company Overview
Sales
23 Cr
Growth: -25.8%
Profit after Tax
-22.9 Cr
Growth: -16.8%
Micro Cap
134 Cr
P/S: 5.8x
Industry P/S: 2.3x
Fundamentals
Sales (Cr) ₹ 23
Growth -25.8%
EBITDA -43.4%
P/S 5.8x
Dividend 0.0%
P/E -5.9x
Book Value ₹ -79.7
PEG Ratio 0.2x
ROE 13.8%
P/B N/A
Shareholding Pattern
Institutions
Sun Pharmaceutical Industries Ltd
4.87 %
K Satish
2.05 %
Brescon Ventures Private Limited
1.97 %
Promoters
Ipca Laboratories Limited
49.65 %
Hemalatha Ravi
12.48 %
Avinash Ravi
9.93 %
Ajay Ravi
0.52 %
R T Ravi
0.11 %
Others
Increase    Decrease    No change
Company Profile Detailed
Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade. KBIL went into public in the year March 1994 to part finance its fermentation technology project.
Investors (43)
avinash....
hemalata...
shaaji.p...